Stock Analysis
Universal Health Services, Inc. Class BUHS
P/E 7.15×· 5Y range 5.67–24.38×· bottom 9% of history
Sector: Healthcare · Industry: Medical Care Facilities
AnalystsHold26 analystsP/E 7.1× sits at the 9th percentile of its 5.089664613278576-year history.
Cash covers 3% of debt · Q2 2026.
PMP Verdict
Mixed fundamentals, cheap valuation
Strengths
- Financial Health60
- Quality60
Mixed business trading cheap — priced for skepticism.
Market context
-1.2% today· Z 2.6σ
Bull Case
- ✓Piotroski F-Score 8/9 — high earnings quality
- ✓ROE 19.9% — efficient capital deployment
- ✓Interest coverage 13.2× — debt well covered
- ✓P/E 7.1× at bottom 9% of 5-year history
What's happening with UHS
Profile
Strong valuation.
How is each axis scored?
- Valuation95/100 · Strong
- P/E vs own history (9th pct)25/25
- FCF yield (7.9%)20/25
- P/S (0.6x)25/25
- EV/EBIT (7.7x)25/25
- Growth52/100 · Moderate
- Revenue CAGR (8.3%)12/25
- Net income CAGR (10.7%)20/25
- EPS CAGR 5Y (18.2%)20/25
- Fwd implied growth (-7.9%)0/25
- Profitability57/100 · Moderate
- ROIC (12.7%)12/25
- ROE (19.9%)20/25
- Net margin (8.4%)13/25
- Operating margin (11.4%)12/25
- Financial Health60/100 · Moderate
- Altman Z (2.27)18/25
- Current ratio (1.12)12/25
- Interest coverage (13.2x)25/25
- Net cash / debt (D/A 32%)5/25
- Quality60/100 · Moderate
- Piotroski F (8/9)25/25
- Beneish M (-2.40)20/25
- FCF conversion (55%)15/25
- Margin stability (σ 2428.8%)0/25
- Moat62/100 · Moderate
- ROIC >12% years (4/10 yrs)6/25
- Median gross margin (40.0%)13/25
- FCF-positive years (10/10 yrs)25/25
- Worst-year net margin (worst 5.0%)18/25
About Universal Health Services, Inc. Class B
Universal Health Services Inc offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. Show more
As of late 2025, the company operated 346 inpatient behavioral health centers, 29 acute care hospitals, and many supportive outpatient facilities. Its operations are concentrated in the U.S, particularly in Nevada (21% of 2025 operating profits), Texas (19%), and California (13%), although it does have some exposure to the UK behavioral health market (6% of 2025 sales) too. While its acute care services account for over 55% of revenue, the behavioral health centers sport higher margins and account for over 55% of pretax profits.
Headquarters: KING OF PRUSSIA, PA · Employees: 101,500 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
TTM Snapshot
trailing twelve months · YoYValuation
95A+P/E (TTM)7.0xA
Grade A: CheapPrice / TTM EPS (own statements) — vs own 5Y history: 5.7x–24.4x · 9th pct
P/FCF13.1xA
Grade A: CheapPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative · Elevated investment — CapEx = 53% of operating cash flow, weighing on reported FCF
FCF Yield7.9%A
Grade A: ValueTTM (OCF − CapEx) / Market Cap — vs own 5Y history: -1.5%–10.8% · 77th pct · Elevated investment — CapEx = 53% of operating cash flow, weighing on reported FCF
P/S (TTM)0.59xA
Grade A: CheapPrice / TTM Revenue (own statements) — vs own 5Y history: 0.5x–1.2x · 13th pct
EV/EBIT7.7xA
Grade A: CheapEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 6.1x–20.7x · 11th pct
EV/Sales0.9xA
Grade A: CheapEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E7.6xA
Grade A: CheapPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio1.40xA
Grade A: FairPrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio0.59A
Grade A: CheapFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield0.45%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio3.3%A
Grade A: SafeDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Elevated investment: Elevated investment — CapEx = 53% of operating cash flow, weighing on reported FCF
Profitability
57CROIC12.7%C
Grade C: AverageNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE19.9%C
Grade C: AverageReturn on Equity. Neg. equity = heavy buybacks
ROA9.8%C
Grade C: AverageReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin8.4%C
Grade C: AverageNet Income / Revenue
Operating Margin11.4%C
Grade C: AverageTTM EBIT / TTM Revenue
Gross Margin44.6%C
Grade C: AverageGross Profit / Revenue
FCF Margin4.7%D
Grade D: LowFCF / Revenue · Elevated investment — CapEx = 53% of operating cash flow, weighing on reported FCF
True FCF Margin4.1%D
Grade D: LowTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost · Elevated investment — CapEx = 53% of operating cash flow, weighing on reported FCF
Growth
52CRevenue CAGR8.3%C
Grade C: OkCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR10.7%C
Grade C: OkCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)18.2%A
Grade A: HighCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth-7.9%D
Grade D: Decl.Analyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)-31.2%A
Grade A: BuybacksShare count change over 5Y
SBC / Net Income6.3%A
Grade A: LowStock-based comp/Net income. >30% = dilution risk
SBC / Revenue0.5%A
Grade A: LowTTM stock-based comp / TTM Revenue
Financial Health
60BAltman Z-Score2.27C
Grade C: Gray zoneBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.12xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio1.04xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage13.2xA
Grade A: StrongEBIT/Interest. >10 Strong
Debt Repayment6.1yC
Grade C: AverageYears to repay net debt via FCF · Elevated investment — CapEx = 53% of operating cash flow, weighing on reported FCF
Net Debt/EBIT2.5xC
Grade C: MedLeverage. <2x Low, >4x High
Debt/Equity0.69xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.03xD
Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash
Quality
60BPiotroski F-Score8/9A
Grade A: StrongFinancial strength 0–9. >7 Strong
Beneish M-Score-2.40A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion55.4%C
Grade C: AverageFCF / Net Income · Elevated investment — CapEx = 53% of operating cash flow, weighing on reported FCF
Margin Stability2428.8%D
Grade D: VolatileEBIT margin std deviation. Lower = stable
Capex / Revenue5.3%C
Grade C: AverageTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover1.16xA
Grade A: HighRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Insider Transactions
SEC Form 4 · 8 records| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
MILLER ALAN B Filed | MILLER ALAN B | BuyJ | +25.5K | |
MILLER ALAN B Filed | MILLER ALAN B | SellJ | -25495 | |
MILLER ALAN B Filed | MILLER ALAN B | BuyJ | +51.0K | |
MILLER ALAN B Filed | MILLER ALAN B | SellJ | -50990 | |
MILLER ALAN B Filed | MILLER ALAN B | BuyJ | +14.2K |
Show 3 more filingsShow fewer filings
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
MILLER ALAN B Filed | MILLER ALAN B | SellJ | -14163 | |
MILLER ALAN B Filed | MILLER ALAN B | BuyJ | +9.4K | |
MILLER ALAN B Filed | MILLER ALAN B | SellJ | -9418 |
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
62BROIC >12% Years4/10 yrsD
Grade D: WeakShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)40.0%C
Grade C: ModerateMedian annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years10/10 yrsA
Grade A: DurableShare of completed fiscal years with positive free cash flow
Net Margin Floor5.0%A
Grade A: DurableWeakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)$25.89
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$2.29
Cash & short-term investments per share (Finnhub)
Book Value / Share$124.12
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$5.26B
Total debt obligations (short + long term)
Cash & Equiv.$138.80M
Cash and short-term investments
Net Debt$5.12B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$7.66B
Shareholders' equity (book value)
Asset / Liability1.92xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$10.69B
Current Market Capitalization
Beta1.12B
Grade B: MarketPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026
Key Insights: Universal Health Services, Inc. Class B (UHS)
UHS is down 1.21% at the last close. Universal Health Services, Inc. Class B meets 8 of 9 Piotroski F-Score criteria, placing its fundamental strength in the top tier of US-listed stocks. Altman Z-Score of 2.27 falls in the grey zone (1.81–2.99) — financial distress is unlikely but not ruled out.
- Beneish M-Score of -2.40 suggests a low likelihood of earnings manipulation.
- Takes ~6.1 years to repay net debt from free cash flow.
- At a valuation score of 95/100, UHS trades near the cheapest end of its own historical range (P/E 7.0).
See how UHS ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all UHS moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Oct 16 | Regular | 182.80 | -2.43% | -2.00 |
| Oct 16 | After-hours | 181.40 | -3.18% | -2.55 |
| Oct 14 | Regular | 186.63 | +4.26% | 3.46 |
| Oct 14 | After-hours | 185.89 | +3.84% | 3.14 |
| Sep 22 | Regular | 181.08 | +3.63% | 2.24 |
Frequently Asked Questions about UHS
What is the current Universal Health Services, Inc. Class B (UHS) stock price?
UHS is trading at $185.10 at the last market close, down 1.21% on the session. PreMarketPrice tracks UHS pre-market, intraday and after-hours prices.
Is UHS stock a buy right now?
PreMarketPrice's quantitative model rates Universal Health Services, Inc. Class B's financial health at 60/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is UHS stock overvalued?
Universal Health Services, Inc. Class B trades at a trailing P/E of 7.0 and our valuation score rates it 95/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Universal Health Services, Inc. Class B report earnings?
No confirmed earnings date is currently scheduled for UHS. The Earnings section lists recent reports and updates as dates are announced.
What sector does Universal Health Services, Inc. Class B operate in?
Universal Health Services, Inc. Class B operates in the Healthcare sector, within the Medical Care Facilities industry. The Related Stocks section lists sector peers for comparison.
What does Universal Health Services, Inc. Class B do?
Universal Health Services Inc offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities.
About Universal Health Services, Inc. Class B (UHS) Stock
Universal Health Services, Inc. Class B (UHS) is a US-listed stock operating in the Healthcare sector, specifically the Medical Care Facilities industry. As of the latest update, Universal Health Services, Inc. Class B is trading at $185.10, down 1.21% on the day with a market capitalization of $10.7 billion. The financial health score for UHS is 60/100, which indicates good financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for UHS stock.
UHS Stock Analysis & Key Metrics
On PreMarketPrice, you can track Universal Health Services, Inc. Class B (UHS) across multiple dimensions:
- Pre-market price & movement: Real-time UHS stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for UHS with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Universal Health Services, Inc. Class B across multiple reporting periods.
- Financial health score: A composite score of 60/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for UHS.
- Sector peers: Compare UHS against 3 other healthcare stocks on key financial metrics.
Is UHS a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Universal Health Services, Inc. Class B (UHS) as an investment. The financial health score of 60/100 suggests good financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Universal Health Services, Inc. Class B (UHS) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.